Mgo One Seven LLC Galapagos Nv Transaction History

Mgo One Seven LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 09, 2019	SELL	$89.61 - $117.78 $27,062 - $35,569	-302 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$87.81 - $110.65 $26,518 - $33,416	302 New	302 $27,000
Q3 2018 Oct 09, 2018	SELL	$90.63 - $120.22 $13,685 - $18,153	-151 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$94.51 - $120.23 $14,271 - $18,154	151 New	151 $15,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.58B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

Stay updated on Mgo One Seven LLC with notifications on news.